Mission
BREAKTHROUGH T1D IS THE LEADING GLOBAL T1D ORGANIZATION WORKING TO ACCELERATE LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT, AND TREAT T1D AND ITS COMPLICATIONS.
Public Charity
BREAKTHROUGH T1D
BREAKTHROUGH T1D, of NEW YORK, NY, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $301.7M in revenue, $281.0M in expenses, $534.6M in total assets. 2,183 publicly reported grants to this organization, totaling roughly $243.2M, appear in IRS filings.
EIN: 231907729
NEW YORK, NY
Specifically Named Diseases
NTEE: G80
Latest filing: 2025
Total Revenue$301.7M
Total Expenses$281.0M
Total Assets$534.6M
Grant Records2,183
Funding Total$243.2M
Filing Years2021–2025
Sample Grants Received
MEDICAL
$399,650
RESEARCH FOR CURE OF TYPE I JUVENILE DIABETES
$117,000
TO HELP ORGANIZATION MEET ITS CHARITABLE PURPOSE
$40,000
Type 1 diabetes research
$27,650
ORGANIZATION'S PURPOSE.
$25,000
Showing up to 5 of 2,183 total records — full history available with membership.
Officers & Directors
CHIEF EXECUTIVE OFFICER
Aaron Kowalski
VICE PRESIDENT, VOLUNTEER ENGAGEMENT
Amy Montalto
CHIEF OF STAFF, TREAS (1/25-3/25)
Annette Freytag
BOARD MEMBER
Carlton Mcmillan
CHAIR, NOMINATING & GOV. COMM.
Christopher Turner
BOARD MEMBER
Claudia Graham Phd
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $301.7M | $281.0M | $534.6M |
| 2024 | $258.1M | $232.1M | $488.1M |
| 2023 | $223.8M | $215.8M | $446.2M |
| 2022 | $238.6M | $162.9M | $389.5M |
| 2021 | $223.0M | $115.5M | $361.3M |
Between 2021 and 2025, reported annual revenue grew from $223.0M to $301.7M (+35%), with total assets most recently reported at $534.6M.
Interactive year-over-year charts and full filing details available with membership.